Rare diseases
Investigational molecules
Locations
Researchdreef 60, 1070 Anderlecht, Belgium
Research activity includes Parkinson’s disease, Alzheimer’s disease, and progressive supranuclear palsy, with additional interest in brain pathophysiology and long-term neurological treatment outcomes.
The portfolio also extends to neurological symptom control in seizure disorders, including therapies for epilepsy, childhood absence epilepsy, juvenile absence epilepsy, and rapid treatment of prolonged seizure episodes.
UCB Biopharma runs clinical trials in conditions such as Myasthenia gravis, Psoriatic arthropathy, Psoriasis, Systemic lupus erythematosus, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Czechia
BulgariaBulgaria
ItalyBelgiumBelgiumItaly
FranceFranceFrance
Austria
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
